0

Journal Articles

in Schizophrenia
 121-140 of 338 Articles
JAMA Psychiatry | 
Original Article |  January 01, 2007 FREE
Elevated Prenatal Homocysteine Levels as a Risk Factor for Schizophrenia
Alan S. Brown, MD; Teodoro Bottiglieri, PhD; Catherine A. Schaefer, PhD; et al.
Arch Gen Psychiatry. 2007;64(1):31-39. doi:10.1001/archpsyc.64.1.31.
JAMA Psychiatry | 
Original Article |  December 01, 2006 FREE
Preserved Subliminal Processing and Impaired Conscious Access in Schizophrenia
Antoine Del Cul, MD; Stanislas Dehaene, PhD; Marion Leboyer, MD, PhD
Arch Gen Psychiatry. 2006;63(12):1313-1323. doi:10.1001/archpsyc.63.12.1313.
JAMA Psychiatry | 
Original Article |  December 01, 2006 FREE
Startle Gating Deficits in a Large Cohort of Patients With Schizophrenia:  Relationship to Medications, Symptoms, Neurocognition, and Level of Function
Neal R. Swerdlow, MD, PhD; Gregory A. Light, PhD; Kristin S. Cadenhead, MD; et al.
Arch Gen Psychiatry. 2006;63(12):1325-1335. doi:10.1001/archpsyc.63.12.1325.
JAMA Psychiatry | 
Original Article |  November 01, 2006 FREE
Early Visual Sensory Deficits as Endophenotypes for Schizophrenia:  High-Density Electrical Mapping in Clinically Unaffected First-Degree Relatives
Sherlyn Yeap, MRCPsych; Simon P. Kelly, PhD; Pejman Sehatpour, MD, PhD; et al.
Arch Gen Psychiatry. 2006;63(11):1180-1188. doi:10.1001/archpsyc.63.11.1180.
JAMA Psychiatry | 
Original Article |  November 01, 2006 FREE
Adverse Effects of Risperidone on Spatial Working Memory in First-Episode Schizophrenia
James L. Reilly, PhD; Margret S. H. Harris, MA; Matcheri S. Keshavan, MD; et al.
Arch Gen Psychiatry. 2006;63(11):1189-1197. doi:10.1001/archpsyc.63.11.1189.
JAMA Neurology | 
Neurological Review |  October 01, 2006 FREE
Cognitive Dysfunction in Schizophrenia:  Convergence of γ-Aminobutyric Acid and Glutamate Alterations
David A. Lewis, MD; Bita Moghaddam, PhD
Arch Neurol. 2006;63(10):1372-1376. doi:10.1001/archneur.63.10.1372.
JAMA Psychiatry | 
Commentary |  October 01, 2006
Outcomes, Costs, and Policy Caution:  A Commentary on the Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)
Robert A. Rosenheck, MD
Arch Gen Psychiatry. 2006;63(10):1074-1076. doi:10.1001/archpsyc.63.10.1074.
JAMA Psychiatry | 
Commentary |  October 01, 2006
Comparative Effectiveness of Antipsychotic Drugs:  A Commentary on Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)
Jeffrey A. Lieberman, MD
Arch Gen Psychiatry. 2006;63(10):1069-1072. doi:10.1001/archpsyc.63.10.1069.
JAMA Psychiatry | 
Original Article |  October 01, 2006 FREE
Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia:  Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)
Peter B. Jones, MD, PhD; Thomas R. E. Barnes, MD, DSc; Linda Davies, MSc; et al.
Arch Gen Psychiatry. 2006;63(10):1079-1087. doi:10.1001/archpsyc.63.10.1079.
JAMA | 
Commentary |  August 02, 2006
Maternal Famine, De Novo Mutations, and Schizophrenia
Jack M. McClellan, MD; Ezra Susser, MD, DrPH; Mary-Claire King, PhD
JAMA. 2006;296(5):582-584. doi:10.1001/jama.296.5.582.
JAMA Psychiatry | 
Original Article |  August 01, 2006 FREE
Genetic Association and Brain Morphology Studies and the Chromosome 8p22 Pericentriolar Material 1 (PCM1) Gene in Susceptibility to Schizophrenia
Hugh M. D. Gurling, MBBS, MD, MPhil, FRCPsych; Hugo Critchley, MB, ChB, DPhil, MRCPsych; Susmita R. Datta, BSc; et al.
Arch Gen Psychiatry. 2006;63(8):844-854. doi:10.1001/archpsyc.63.8.844.
JAMA Psychiatry | 
Original Article |  July 01, 2006 FREE
Cognitive and Magnetic Resonance Imaging Brain Morphometric Correlates of Brain-Derived Neurotrophic Factor Val66Met Gene Polymorphism in Patients With Schizophrenia and Healthy Volunteers
Beng-Choon Ho, MRCPsych; Peter Milev, MD, PhD; Daniel S. O’Leary, PhD; et al.
Arch Gen Psychiatry. 2006;63(7):731-740. doi:10.1001/archpsyc.63.7.731.
JAMA Psychiatry | 
Original Article |  July 01, 2006 FREE
Childhood-Onset Schizophrenia:  A Double-Blind, Randomized Clozapine-Olanzapine Comparison
Philip Shaw, MD; Alex Sporn, MD; Nitin Gogtay, MD; et al.
Arch Gen Psychiatry. 2006;63(7):721-730. doi:10.1001/archpsyc.63.7.721.
JAMA | 
Medical News and Perspectives |  June 14, 2006
Signaling Proteins Boost Drug Activity
JAMA. 2006;295(22):2590. doi:10.1001/jama.295.22.2590.
JAMA Psychiatry | 
Original Article |  June 01, 2006 FREE
Proof-of-Concept Trial of an α7 Nicotinic Agonist in Schizophrenia
Ann Olincy, MD; Josette G. Harris, PhD; Lynn L. Johnson, PharmD; et al.
Arch Gen Psychiatry. 2006;63(6):630-638. doi:10.1001/archpsyc.63.6.630.
JAMA Psychiatry | 
Original Article |  June 01, 2006 FREE
Atypical Antipsychotic Agents in the Treatment of Violent Patients With Schizophrenia and Schizoaffective Disorder
Menahem I. Krakowski, MD, PhD; Pal Czobor, PhD; Leslie Citrome, MD, MPh; et al.
Arch Gen Psychiatry. 2006;63(6):622-629. doi:10.1001/archpsyc.63.6.622.
JAMA Psychiatry | 
Original Article |  May 01, 2006 FREE
A National Study of Violent Behavior in Persons With Schizophrenia
Jeffrey W. Swanson, PhD; Marvin S. Swartz, MD; Richard A. Van Dorn, PhD; et al.
Arch Gen Psychiatry. 2006;63(5):490-499. doi:10.1001/archpsyc.63.5.490.
JAMA Psychiatry | 
Original Article |  April 01, 2006 FREE
The Neural Basis of Relational Memory Deficits in Schizophrenia
Dost Öngür, MD, PhD; Thomas J. Cullen, MD, PhD; Daniel H. Wolf, MD, PhD; et al.
Arch Gen Psychiatry. 2006;63(4):356-365. doi:10.1001/archpsyc.63.4.356.
JAMA Psychiatry | 
Original Article |  April 01, 2006 FREE
Variation at the DAOA/G30 Locus Influences Susceptibility to Major Mood Episodes but Not Psychosis in Schizophrenia and Bipolar Disorder
Nigel M. Williams, PhD; Elaine K. Green, PhD; Stuart Macgregor, PhD; et al.
Arch Gen Psychiatry. 2006;63(4):366-373. doi:10.1001/archpsyc.63.4.366.
JAMA Psychiatry | 
Original Article |  March 01, 2006 FREE
Familial Aggregation of Eye-Tracking Endophenotypes in Families of Schizophrenic Patients
L. Elliot Hong, MD; Braxton D. Mitchell, PhD; Matthew T. Avila, PhD; et al.
Arch Gen Psychiatry. 2006;63(3):259-264. doi:10.1001/archpsyc.63.3.259.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Psychiatry
Original Article  |  May 8, 2013
Rapid Improvement of Acute Schizophrenia Symptoms After Intravenous Sodium Nitroprusside:  A Randomized, Double-blind, Placebo-Controlled Trial
Jaime E. C. Hallak, MD, PhD; Joao Paulo Maia-de-Oliveira, MD; Joao Abrao, MD, PhD; et al.
JAMA Psychiatry
Editorial  |  May 8, 2013
Nitric Oxide and Symptom Reduction in Schizophrenia
Joseph T. Coyle, MD
JAMA
Lab Reports  |  May 01, 2013
Signal of Schizophrenia Risk
Tracy Hampton, PhD
JAMA Psychiatry
Original Article  |  March 6, 2013
Neuroimaging Evidence for the Deficit Subtype of Schizophrenia
Aristotle N. Voineskos, MD, PhD, FRCPC; George Foussias, MD, MSc, FRCPC; Jason Lerch, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems